Pharming Group NV
AEX:PHARM

Watchlist Manager

Pharming Group NV

AEX:PHARM

Watchlist

Dividends

Price: 0.7275 EUR -1.09%

Market Cap: 493.5m EUR

Have any thoughts about
Pharming Group NV?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 0.7275 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

PHARM Alert

Pharming Group NV

0.7275

-0.0080 (-1.09%)

52 Week Range	0.6545 1.199
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Pharming Group NV

What unique competitive advantages
does Pharming Group NV hold over its rivals?

What risks and challenges
does Pharming Group NV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Pharming Group NV.

What unique competitive advantages
does Pharming Group NV hold over its rivals?

What risks and challenges
does Pharming Group NV face in the near future?

Has there been any significant insider trading activity
in Pharming Group NV recently?

Summarize the latest earnings call
of Pharming Group NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharming Group NV.

Provide P/S
for Pharming Group NV.

Provide P/E
for Pharming Group NV.

Provide P/OCF
for Pharming Group NV.

Provide P/FCFE
for Pharming Group NV.

Provide P/B
for Pharming Group NV.

Provide EV/S
for Pharming Group NV.

Provide EV/GP
for Pharming Group NV.

Provide EV/EBITDA
for Pharming Group NV.

Provide EV/EBIT
for Pharming Group NV.

Provide EV/OCF
for Pharming Group NV.

Provide EV/FCFF
for Pharming Group NV.

Provide EV/IC
for Pharming Group NV.

Show me price targets
for Pharming Group NV made by professional analysts.

What are the Revenue projections
for Pharming Group NV?

How accurate were the past Revenue estimates
for Pharming Group NV?

What are the Net Income projections
for Pharming Group NV?

How accurate were the past Net Income estimates
for Pharming Group NV?

What are the EPS projections
for Pharming Group NV?

How accurate were the past EPS estimates
for Pharming Group NV?

What are the EBIT projections
for Pharming Group NV?

How accurate were the past EBIT estimates
for Pharming Group NV?

Compare the revenue forecasts
for Pharming Group NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharming Group NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharming Group NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharming Group NV compared to its peers.

Compare the P/E ratios
of Pharming Group NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharming Group NV with its peers.

Analyze the financial leverage
of Pharming Group NV compared to its main competitors.

Show all profitability ratios
for Pharming Group NV.

Provide ROE
for Pharming Group NV.

Provide ROA
for Pharming Group NV.

Provide ROIC
for Pharming Group NV.

Provide ROCE
for Pharming Group NV.

Provide Gross Margin
for Pharming Group NV.

Provide Operating Margin
for Pharming Group NV.

Provide Net Margin
for Pharming Group NV.

Provide FCF Margin
for Pharming Group NV.

Show all solvency ratios
for Pharming Group NV.

Provide D/E Ratio
for Pharming Group NV.

Provide D/A Ratio
for Pharming Group NV.

Provide Interest Coverage Ratio
for Pharming Group NV.

Provide Altman Z-Score Ratio
for Pharming Group NV.

Provide Quick Ratio
for Pharming Group NV.

Provide Current Ratio
for Pharming Group NV.

Provide Cash Ratio
for Pharming Group NV.

What is the historical Revenue growth
over the last 5 years for Pharming Group NV?

What is the historical Net Income growth
over the last 5 years for Pharming Group NV?

What is the current Free Cash Flow
of Pharming Group NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharming Group NV.

PHARM

Balance Sheet

Other Long-Term Assets

Pharming Group NV
Other Long-Term Assets

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Pharming Group NV
Other Long-Term Assets Peer Comparison

Comparables:

PRQR

QURE

ARGX

MRUS

LVTX

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

	Other Long-Term Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Pharming Group NV AEX:PHARM	Other Long-Term Assets $38.4m	CAGR 3-Years 27%	CAGR 5-Years 4%	CAGR 10-Years 69%
ProQR Therapeutics NV NASDAQ:PRQR	Other Long-Term Assets N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Uniqure NV NASDAQ:QURE	Other Long-Term Assets $12.3m	CAGR 3-Years -17%	CAGR 5-Years 34%	CAGR 10-Years 26%
argenx SE XBRU:ARGX	Other Long-Term Assets $224.2m	CAGR 3-Years 133%	CAGR 5-Years 263%	CAGR 10-Years N/A
Merus NV NASDAQ:MRUS	Other Long-Term Assets $3.5m	CAGR 3-Years 9%	CAGR 5-Years 28%	CAGR 10-Years N/A
LAVA Therapeutics NV NASDAQ:LVTX	Other Long-Term Assets $319k	CAGR 3-Years -26%	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Pharming Group NV's Other Long-Term Assets?

Other Long-Term Assets
38.4m USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Other Long-Term Assets amounts to 38.4m USD.

What is Pharming Group NV's Other Long-Term Assets growth rate?

Other Long-Term Assets CAGR 10Y
69%

Over the last year, the Other Long-Term Assets growth was 36%. The average annual Other Long-Term Assets growth rates for Pharming Group NV have been 27% over the past three years , 4% over the past five years , and 69% over the past ten years .

Pharming Group NV
AEX:PHARM

Pharming Group NV
Other Long-Term Assets

Pharming Group NV
Other Long-Term Assets Peer Comparison

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

See Also

What is Pharming Group NV's Other Long-Term Assets?

Other Long-Term Assets
38.4m USD

What is Pharming Group NV's Other Long-Term Assets growth rate?

Other Long-Term Assets CAGR 10Y
69%

Company

Help

Tools

Stocks

Pharming Group NV AEX:PHARM

Pharming Group NV Other Long-Term Assets

Pharming Group NV Other Long-Term Assets Peer Comparison

Competitive Other Long-Term Assets Analysis Latest Figures & CAGR of Competitors

See Also

What is Pharming Group NV's Other Long-Term Assets? Other Long-Term Assets 38.4m USD

What is Pharming Group NV's Other Long-Term Assets growth rate? Other Long-Term Assets CAGR 10Y 69%

Company

Help

Tools

Stocks

Pharming Group NV
AEX:PHARM

Pharming Group NV
Other Long-Term Assets

Pharming Group NV
Other Long-Term Assets Peer Comparison

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

What is Pharming Group NV's Other Long-Term Assets?

Other Long-Term Assets
38.4m USD

What is Pharming Group NV's Other Long-Term Assets growth rate?

Other Long-Term Assets CAGR 10Y
69%